Dawn Christine Maroney Sells 27,243 Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) President Dawn Christine Maroney sold 27,243 shares of the stock in a transaction dated Wednesday, March 12th. The shares were sold at an average price of $15.43, for a total transaction of $420,359.49. Following the completion of the transaction, the president now directly owns 2,276,732 shares of the company's stock, valued at approximately $35,129,974.76. The trade was a 1.18 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Dawn Christine Maroney also recently made the following trade(s):

• On Thursday, March 6th, Dawn Christine Maroney sold 278,917 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.53, for a total transaction of $4,331,581.01.
• On Tuesday, February 18th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $13.72, for a total value of $411,600.00.
• On Wednesday, January 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $13.61, for a total transaction of $408,300.00.

Alignment Healthcare Trading Up 1.9 %

NASDAQ:ALHC traded up $0.30 on Monday, hitting $16.09. The stock had a trading volume of 2,691,822 shares, compared to its average volume of 1,400,843. The company has a fifty day moving average price of $14.38 and a two-hundred day moving average price of $12.46. The stock has a market cap of $3.09 billion, a price-to-earnings ratio of -20.90 and a beta of 1.49. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 1.82. Alignment Healthcare, Inc. has a 1-year low of $4.46 and a 1-year high of $16.30.

Remove Ads

Analysts Set New Price Targets

Several research firms have commented on ALHC. Bank of America upped their price target on shares of Alignment Healthcare from $15.50 to $18.50 and gave the company a "buy" rating in a report on Tuesday, March 4th. Stephens reiterated an "overweight" rating and issued a $17.00 price objective on shares of Alignment Healthcare in a report on Monday, February 24th. Barclays increased their target price on Alignment Healthcare from $8.00 to $9.00 and gave the company an "underweight" rating in a report on Friday, February 28th. Stifel Nicolaus boosted their price target on shares of Alignment Healthcare from $16.00 to $18.00 and gave the stock a "buy" rating in a research report on Friday, February 28th. Finally, Piper Sandler increased their price objective on shares of Alignment Healthcare from $14.00 to $21.00 and gave the company an "overweight" rating in a report on Tuesday, March 4th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $14.83.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. R Squared Ltd acquired a new position in Alignment Healthcare in the fourth quarter valued at about $55,000. RiverPark Advisors LLC purchased a new stake in shares of Alignment Healthcare in the 4th quarter valued at approximately $106,000. Tower Research Capital LLC TRC lifted its holdings in shares of Alignment Healthcare by 146.7% in the 4th quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company's stock worth $119,000 after acquiring an additional 6,286 shares during the last quarter. Ballentine Partners LLC purchased a new position in shares of Alignment Healthcare during the 4th quarter worth approximately $121,000. Finally, Aigen Investment Management LP acquired a new stake in Alignment Healthcare in the 4th quarter valued at approximately $129,000. 86.19% of the stock is currently owned by institutional investors and hedge funds.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.